MacroGenics | MGNX - Ebitda





Ebitda Perubahan Tanggal
AbbVie USD 3.69B 1.68B 2026-03
Amgen USD 3.86B 1.28B 2026-03
AstraZeneca USD 5.16B 510M 2026-06
Biogen USD 649.7M 76.5M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Eli Lilly USD 10.29B 1.86B 2026-03
Genmab DKK 401M 186M 2026-06
Geron USD 3.83M 25.12M 2026-03
Gilead Sciences USD 3.51B 489M 2026-03
J&J USD 8.27B 1.08B 2026-03
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD -30.2M 52.15M 2026-03
Merck USD -1.54B 7.84B 2026-03
Pfizer USD 6.01B 18M 2026-06
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Xencor USD -34.63M 86.74M 2026-06